Jerome Ritz
Jerome Ritz
Dana-Farber Cancer Institute
Verified email at
Cited by
Cited by
An immunogenic personal neoantigen vaccine for patients with melanoma
PA Ott, Z Hu, DB Keskin, SA Shukla, J Sun, DJ Bozym, W Zhang, A Luoma, ...
Nature 547 (7662), 217-221, 2017
Biology and clinical relevance of human natural killer cells
MJ Robertson, J Ritz
Interleukin-2 and regulatory T cells in graft-versus-host disease
J Koreth, K Matsuoka, HT Kim, SM McDonough, B Bindra, EP Alyea III, ...
New England Journal of Medicine 365 (22), 2055-2066, 2011
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
DB Keskin, AJ Anandappa, J Sun, I Tirosh, ND Mathewson, S Li, ...
Nature 565 (7738), 234-239, 2019
Activation of a novel human transforming gene, ret, by DNA rearrangement
M Takahashi, J Ritz, GM Cooper
Cell 42 (2), 581-588, 1985
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
E Zorn, EA Nelson, M Mohseni, F Porcheray, H Kim, D Litsa, R Bellucci, ...
Blood 108 (5), 1571-1579, 2006
Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma
JG Gribben, AS Freedman, D Neuberg, DC Roy, KW Blake, SD Woo, ...
New England Journal of Medicine 325 (22), 1525-1533, 1991
Expression of Epstein–Barr virus transformation–associated genes in tissues of patients with EBV lymphoproliferative disease
L Young, C Alfieri, K Hennessy, H Evans, C O'Hara, KC Anderson, J Ritz, ...
New England Journal of Medicine 321 (16), 1080-1085, 1989
A monoclonal antibody to human acute lymphoblastic leukaemia antigen
J Ritz, JM Pesando, J Notis-McConarty, H Lazarus, SF Schlossman
Nature 283 (5747), 583-585, 1980
The elusive nature and function of mesenchymal stem cells
C Nombela-Arrieta, J Ritz, LE Silberstein
Nature reviews Molecular cell biology 12 (2), 126-131, 2011
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
MB Atkins, MJ Robertson, M Gordon, MT Lotze, M DeCoste, JS DuBois, ...
Clinical cancer research: an official journal of the American Association …, 1997
Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.
EL Reinherz, PC Kung, JM Pesando, J Ritz, G Goldstein, SF Schlossman
The Journal of experimental medicine 150 (6), 1472-1482, 1979
Expression of myeloid differentiation antigens on normal and malignant myeloid cells.
JD Griffin, J Ritz, LM Nadler, SF Schlossman
The Journal of clinical investigation 68 (4), 932-941, 1981
CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation
J Deng, ES Wang, RW Jenkins, S Li, R Dries, K Yates, S Chhabra, ...
Cancer discovery 8 (2), 216-233, 2018
Ipilimumab for patients with relapse after allogeneic transplantation
MS Davids, HT Kim, P Bachireddy, C Costello, R Liguori, A Savell, ...
New England Journal of Medicine 375 (2), 143-153, 2016
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer
J Nemunaitis, SN Rabinowe, JW Singer, PJ Bierman, JM Vose, ...
New England Journal of Medicine 324 (25), 1773-1778, 1991
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
E Zorn, HT Kim, SJ Lee, BH Floyd, D Litsa, S Arumugarajah, R Bellucci, ...
Blood 106 (8), 2903-2911, 2005
Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.
MA Caligiuri, A Zmuidzinas, TJ Manley, H Levine, KA Smith, J Ritz
The Journal of experimental medicine 171 (5), 1509-1526, 1990
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease
K Matsuoka, J Koreth, HT Kim, G Bascug, S McDonough, Y Kawano, ...
Science translational medicine 5 (179), 179ra43-179ra43, 2013
A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
LM Nadler, J Ritz, R Hardy, JM Pesando, SF Schlossman, P Stashenko
The Journal of clinical investigation 67 (1), 134-140, 1981
The system can't perform the operation now. Try again later.
Articles 1–20